HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Irene Paterniti Selected Research

3-nitrotyrosine

1/2014Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies.
4/2012Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α.
10/2011Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats.
7/2011Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice.
2/2011Modulation of NADPH oxidase activation in cerebral ischemia/reperfusion injury in rats.
2/2011Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury.
9/2010Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice.
5/2010Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury.
2/2010Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma.
8/2009Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Irene Paterniti Research Topics

Disease

56Inflammation (Inflammations)
05/2022 - 08/2009
29Spinal Cord Injuries (Spinal Cord Injury)
11/2020 - 05/2009
18Neuroinflammatory Diseases
07/2022 - 01/2011
13Ischemia
11/2021 - 02/2010
11Myelitis
01/2014 - 05/2009
10Reperfusion Injury
11/2021 - 02/2010
9Wounds and Injuries (Trauma)
01/2021 - 02/2011
8Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022 - 01/2014
8Neoplasms (Cancer)
02/2022 - 02/2018
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 12/2014
6Parkinson Disease (Parkinson's Disease)
07/2022 - 01/2012
6Pleurisy (Pleuritis)
05/2014 - 02/2010
5Edema (Dropsy)
11/2020 - 11/2010
5Aneurysm (Aneurysms)
01/2019 - 08/2011
5Shock
07/2011 - 02/2010
4Glioblastoma (Glioblastoma Multiforme)
10/2022 - 12/2020
4Psoriasis (Pustulosis Palmaris et Plantaris)
03/2022 - 04/2016
4Body Weight (Weight, Body)
05/2012 - 02/2010
4Pneumonia (Pneumonitis)
10/2011 - 02/2010
4Multiple Organ Failure (MODS)
07/2011 - 02/2010
4Septic Shock (Toxic Shock Syndrome)
07/2011 - 02/2010
3Migraine Disorders (Migraine)
04/2022 - 02/2020
3Mouth Neoplasms (Oral Cancer)
12/2021 - 07/2021
3Hyperalgesia
02/2020 - 11/2010
3Colitis
04/2016 - 01/2010
3Necrosis
04/2016 - 10/2011
3Brain Ischemia (Cerebral Ischemia)
01/2016 - 02/2011
3Lung Injury
05/2014 - 07/2011
3Spinal Cord Compression
07/2013 - 04/2011
3Brain Injuries (Brain Injury)
04/2013 - 02/2011
3Pancreatitis
07/2012 - 05/2012
3Periodontitis
01/2011 - 01/2010
2Alzheimer Disease (Alzheimer's Disease)
07/2022 - 01/2014
2Squamous Cell Carcinoma of Head and Neck
12/2021 - 10/2021
2Acute Lung Injury
08/2021 - 04/2010

Drug/Important Bio-Agent (IBA)

21CytokinesIBA
03/2022 - 05/2009
12palmidrolIBA
05/2016 - 08/2011
113-nitrotyrosineIBA
01/2014 - 05/2009
10Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2022 - 05/2009
10Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2020 - 05/2009
9CarrageenanIBA
04/2020 - 02/2010
7LuteolinIBA
10/2020 - 07/2013
7Peroxidase (Myeloperoxidase)IBA
01/2018 - 01/2010
7Neuroprotective AgentsIBA
01/2018 - 02/2011
6LigandsIBA
10/2022 - 02/2010
6Proteins (Proteins, Gene)FDA Link
07/2022 - 05/2010
6AntioxidantsIBA
06/2022 - 07/2013
6(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
07/2012 - 02/2010
6NF-kappa B (NF-kB)IBA
07/2012 - 05/2009
5Prolyl OligopeptidasesIBA
11/2021 - 12/2020
5EnzymesIBA
01/2021 - 01/2010
5Pharmaceutical PreparationsIBA
01/2021 - 01/2011
5LipopolysaccharidesIBA
01/2021 - 08/2017
5FumaratesIBA
07/2020 - 04/2016
5Dimethyl FumarateIBA
07/2020 - 04/2016
5Glial Fibrillary Acidic ProteinIBA
01/2018 - 04/2013
5co-ultraPEALutIBA
01/2016 - 07/2013
5Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
12/2014 - 02/2010
4MelatoninIBA
03/2022 - 08/2009
44-phenylbutanoyl-prolylcyanopyrrolidineIBA
12/2021 - 07/2021
4Nerve Growth Factors (Neurotrophins)IBA
04/2021 - 04/2011
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2020 - 11/2010
4Transcription Factors (Transcription Factor)IBA
01/2019 - 05/2009
4Liver X ReceptorsIBA
01/2017 - 02/2010
4olprinoneIBA
10/2011 - 07/2010
4NADPH Oxidases (NAD(P)H oxidase)IBA
07/2011 - 02/2011
4ZymosanIBA
07/2011 - 02/2010
4acetovanillone (apocynin)IBA
03/2011 - 11/2010
4PPAR-betaIBA
08/2010 - 02/2010
3InflammasomesIBA
10/2021 - 01/2019
3xyloglucanIBA
09/2021 - 01/2020
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2020 - 01/2010
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 02/2010
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017 - 11/2010
3DinitrobenzenesIBA
04/2016 - 01/2010
3Fatty Acids (Saturated Fatty Acids)IBA
08/2015 - 05/2009
3CeruletideIBA
07/2012 - 05/2012
3oleuropein aglyconeIBA
05/2012 - 08/2011
3Olive OilIBA
05/2012 - 08/2011
32- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
05/2012 - 02/2010
3Mitogen-Activated Protein KinasesIBA
05/2012 - 02/2011
3GlucocorticoidsIBA
01/2012 - 05/2009
3Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
10/2011 - 05/2010
3Poly Adenosine Diphosphate RiboseIBA
07/2011 - 02/2010
3Tyrosine (L-Tyrosine)FDA Link
11/2010 - 01/2010
3T0901317IBA
02/2010 - 02/2010
2Therapeutic UsesIBA
10/2022 - 07/2020
2diazonaphthalenedisulfonic acid (NDS)IBA
06/2022 - 07/2020
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
05/2022 - 01/2012
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
05/2022 - 12/2020
2Butyric Acid (Butanoic Acid)IBA
04/2022 - 10/2021
2Volatile Fatty AcidsIBA
04/2022 - 10/2021
2sodium propionateIBA
04/2022 - 10/2021
2MicroRNAs (MicroRNA)IBA
02/2022 - 04/2021
2Biological ProductsIBA
02/2022 - 01/2016
23- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
10/2021 - 11/2020

Therapy/Procedure

14Laminectomy
01/2019 - 05/2009
11Therapeutics
04/2022 - 02/2010
5Surgical Instruments (Clip)
01/2019 - 08/2011
3Drug Therapy (Chemotherapy)
04/2021 - 01/2015